Table 1.
Author, Year | Country | Study Design |
Sample Size | Main Findings Comparing Cases to Controls |
---|---|---|---|---|
Scanlan, 20083 | Belgium | Case-control | 20 cancers / 20 polyps / 20 controls | ↑ diversity of the Clostridium leptum and C. coccoides subgroups |
Sobhani, 20114 | France | Case-control | 60 cancers / 119 controls | ↑ Bacteroides/Prevotella |
Wang, 20125 | China | Case-control | 46 cancers / 56 controls | ↑ Bacteroides fragilis and opportunistic pathogens; ↓ butyrate-producing bacteria |
Ahn, 20136 | USA | Case-control | 47 cancers / 94 controls | ↓ diversity; ↓ Clostridia; ↑ Fusobacterium, Porphyromonas; |
Zackular, 20147 | USA | Case-control | 30 cancers / 30 adenomas / 30 controls | ↑ Bacteroides fragilis, Fusobacterium, Porphyromonas; ↓ butyrate-producing bacteria |
Zeller, 20148 | France | Case-control | 91 cancers / 42 adenomas / 358 controls | ↑ Bacteroidetes, Fusobacteria and Proteobacteria; ↓ Actinobacteria and Firmicutes |
Feng, 20159 | Austria | Case-control | 41 cancers / 42 adenomas / 55 controls | ↑ B. dorei, B. vulgatus, E. coli, Fusobacterium; ↓ Lactobacillus and Bifidobacterium |
Vogtmann, 201610 | USA, France | Case-control | 52 cancers / 52 controls | ↑ Fusobacterium, Porphyromonas, Clostridia |
Yu, 201711 | Denmark, France, Austria | Case-control | 74 cancers / 54 controls | ↑ Peptostreptococcus stomatis, F. nucleatum, Parvimonas micra, Solobacterium moorei |
Shah, 201712 | Multiple countries | Pooled analysis of case-control studies | 195 cancers / 79 adenomas / 235 controls | ↑ Parvimonas micra ATCC 33270,Streptococcus anginosus, yet-to-becultured members of Proteobacteria |
Liang, 201713 | China | Case-control | 203 cancers / 236 controls | ↑ F. nucleatum, Clostridium hathewayi; ↓ B. clarus |
Flemer, 201714 | Ireland | Case-control | 43 cancers / 37 controls | ↓ Lachnospiraceae incertae sedis and Coprococcus |